Insider Selling: Cryolife VP Sells 5,000 Shares of Stock (CRY)
Cryolife (NYSE:CRY) VP Bruce G. Anderson sold 5,000 shares of Cryolife stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $10.05, for a total transaction of $50,250.00. Following the completion of the sale, the vice president now directly owns 34,564 shares of the company’s stock, valued at approximately $347,368. The sale was disclosed in a document filed with the SEC, which is available at this link.
Shares of Cryolife (NYSE:CRY) traded up 0.30% on Tuesday, hitting $10.11. The stock had a trading volume of 102,919 shares. Cryolife has a 52-week low of $6.01 and a 52-week high of $12.14. The stock’s 50-day moving average is $9.73 and its 200-day moving average is $9.49. The company has a market cap of $282.3 million and a price-to-earnings ratio of 18.81.
Cryolife (NYSE:CRY) last posted its quarterly earnings results on Thursday, July 24th. The company reported $0.08 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.05 by $0.03. The company had revenue of $34.69 million for the quarter, compared to the consensus estimate of $35.72 million. During the same quarter in the prior year, the company posted $0.08 earnings per share. The company’s quarterly revenue was up 3.6% on a year-over-year basis. Analysts expect that Cryolife will post $0.20 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, September 19th. Investors of record on Friday, September 12th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend is Wednesday, September 10th.
CryoLife, Inc (NYSE:CRY) is a biological medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.